IP Verse

New Use Of A Combination Of Sacubitril And Valsartan

Patent No. EP3411021 (titled "New Use Of A Combination Of Sacubitril And Valsartan") was filed by Novartis on Feb 2, 2017. The application was issued on May 14, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CAMULONSep 1, 2025REDDIE & GROSE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3411021

NOVARTIS
Application Number
EP17703477A
Filing Date
Feb 2, 2017
Status
Granted And Under Opposition
Apr 11, 2025
Publication Date
May 14, 2025
External Links
Slate, Register , Google Patents